NCT05159388 A Study of PRS-344/S095012 (PD-L1x4-1BB Bispecific Antibody-Anticalin Fusion) in Patients With Solid Tumors Status COMPLETED Phase PHASE1/PHASE2
NCT05159245 The Finnish National Study to Facilitate Patient Access to Targeted Anti-cancer Drugs Status RECRUITING Phase PHASE2
NCT05150405 A Phase Ia Clinical Study of QLF31907 Injection in Patients With Advanced Malignant Tumors Status RECRUITING Phase PHASE1
NCT05136937 A Clinical Study of Intratumoral Administration of RT-01 in Patients With Advanced Solid Tumors Status UNKNOWN Phase PHASE1
NCT05134636 Text-based Intervention to Minimize the Time Burden of Routine Cancer Care Status COMPLETED Phase NA
NCT05128487 A Study of NDI 1150-101 in Patients With Solid Tumors Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT05126927 A PET Imaging Agent to Assess the Level of Tumor Tissue-infiltrating CD8 + T Cells in Patients With Solid Tumors Status COMPLETED Phase EARLY_PHASE1
NCT05120375 Assessment of Safety and Preliminary Efficacy With BAT6021 in Solid Tumor Patients in China Status TERMINATED Phase PHASE1
NCT05119998 A Phase I Study of IBI325 in Patients With Advanced Solid Tumor Status COMPLETED Phase PHASE1
NCT05119907 Study of Sacituzumab Govitecan in Patients With Solid Tumor Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05115500 ADC Combined With Hypofractionated Radiotherapy, PD-1/PD-L1 Sequential GM-CSF and IL-2 for Treatment of HER-2 Positive Advanced Solid Tumors(PRaG3.0) Status UNKNOWN Phase PHASE2
NCT05109832 A Study of Absorption-Distribution-Metabolism-Excretion (ADME) of [14C]IMP4297 to China Healthy Male Subjects Status COMPLETED Phase PHASE1
NCT05103631 Interleukin-15 Armored Glypican 3-specific Chimeric Antigen Receptor Expressed in Autologous T Cells for Solid Tumors Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT05103358 Phase 2 Basket Trial of Nab-sirolimus in Patients With Malignant Solid Tumors With Pathogenic Alterations in TSC1/TSC2 Genes (PRECISION 1) Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05097781 Local Radiotherapy in Combination With Immunotherapy in Advanced Solid Tumors Patients Status UNKNOWN Phase PHASE2
NCT05095441 A Clinical Study of Intratumoral MVR-C5252 (C5252) in Patients With Recurrent or Progressive Glioblastoma Status NOT_YET_RECRUITING Phase PHASE1
NCT05093322 A Study of Surufatinib in Combination With Gemcitabine in Pediatric, Adolescent, and Young Adult Patients With Recurrent or Refractory Solid Tumors Status COMPLETED Phase PHASE1/PHASE2
NCT05088070 Clinical Study of SPH3348 Tablets, a C-Met Inhibitor, in Patients with Advanced Solid Tumors Status COMPLETED Phase PHASE1